Development of a vaccine construct against Pneumocystis jirovecii pneumonia using computational tools

This study uses an immunoinformatics (computer-guided) approach to design a candidate vaccine against Pneumocystis jirovecii, a fungus that causes serious pneumonia in people with weakened immune systems. The team screened the pathogen’s major surface glycoprotein for antigenic epitopes, filtered them for safety and immune-activating potential, and assembled ten into a vaccine construct with adjuvants. Molecular docking, molecular dynamics, and immune-simulation tests suggested the design binds Toll-like receptors stably and could provoke a useful immune response, a starting point for laboratory validation.